Published in Mayo Clin Proc on September 01, 2000
Grapefruit juice: potential drug interactions. CMAJ (2002) 1.44
Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J (2011) 1.35
Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol (2003) 1.21
Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol (2010) 1.20
Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. Br J Cancer (2003) 1.12
Dietary effects on drug metabolism and transport. Clin Pharmacokinet (2003) 1.11
Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Dispos (2008) 1.03
Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur J Clin Pharmacol (2009) 0.95
Use of statin therapy to reduce cardiovascular risk in older patients. Curr Gerontol Geriatr Res (2010) 0.84
Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Eur J Clin Pharmacol (2007) 0.84
Medicinal importance of grapefruit juice and its interaction with various drugs. Nutr J (2007) 0.83
Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicity. AAPS J (2013) 0.81
The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol (2012) 0.79
The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. Daru (2014) 0.79
Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review. Evid Based Complement Alternat Med (2013) 0.78
Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice. Eur J Clin Pharmacol (2008) 0.77
Different influences on tacrolimus pharmacokinetics by coadministrations of zhi ke and zhi shi in rats. Evid Based Complement Alternat Med (2011) 0.77
The role of diet on the clinical pharmacology of oral antineoplastic agents. Eur J Clin Pharmacol (2011) 0.77
Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity. Exp Clin Cardiol (2003) 0.76
Suspected Interaction of Cranberry Juice Extracts and Tacrolimus Serum Levels: A Case Report. Cureus (2016) 0.75
Drug-Induced Liver Injury in HIV Patients. Gastroenterol Hepatol (N Y) (2006) 0.75
Ketolides in the treatment of community-acquired respiratory tract infections: A review. Curr Ther Res Clin Exp (2005) 0.75
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med (1980) 2.51
Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet (1978) 2.10
Mycophenolate mofetil for Crohn's disease? Lancet (1999) 2.03
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Gastroenterology (1999) 1.84
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57
Intravenous azathioprine in severe ulcerative colitis: a pilot study. Am J Gastroenterol (2000) 1.46
N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet (1983) 1.41
Methylphenidate: its pharmacology and uses. Mayo Clin Proc (2000) 1.39
Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J Biol Chem (1999) 1.38
Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity. Antimicrob Agents Chemother (1979) 1.33
Hypoprothrombinemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics. J Antimicrob Chemother (1983) 1.28
Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics. Proc Natl Acad Sci U S A (1984) 1.16
Aminoglycoside inhibition of a renal phosphatidylinositol phospholipase C. J Pharmacol Exp Ther (1982) 1.14
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut (2001) 1.12
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut (2001) 1.11
Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats. Antimicrob Agents Chemother (1984) 1.07
Utility of a "swish and spit" technique for the collection of buccal cells for TAP haplotype determination. Mayo Clin Proc (1995) 1.04
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Ann Intern Med (1984) 1.02
Measles antibody seroprevalence rates among immunized Inuit, Innu and Caucasian subjects. Vaccine (1999) 1.02
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology (1995) 1.01
Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia. Antimicrob Agents Chemother (1978) 0.99
Letter: Overdoses of chloramphenicol. JAMA (1975) 0.98
Measles reimmunization in children seronegative after initial immunization. JAMA (1997) 0.97
Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett (1998) 0.96
Presence of alpha-1-antitrypsin on mitogen-stimulated human lymphocytes. J Immunol (1979) 0.94
Initial aminoglycoside levels in the critically ill. Crit Care Med (1983) 0.94
Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase. Biochem Pharmacol (2000) 0.94
Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram. Biochemistry (1997) 0.93
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration. Gut (1996) 0.93
Actions of polyamines on lipid and glucose metabolism of fat cells. Biochem Biophys Res Commun (1971) 0.91
Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice. Mayo Clin Proc (1998) 0.90
Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study. Aliment Pharmacol Ther (1997) 0.89
Gentamicin uptake by renal tubule brush border membrane vesicles. J Pharmacol Exp Ther (1980) 0.89
Neomycin inhibition of adenosine triphosphatase: evidence for a neomycin-phospholipid interaction. Antimicrob Agents Chemother (1980) 0.88
Androgen deprivation as a strategy for prostate cancer chemoprevention. J Natl Cancer Inst (1997) 0.86
A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther (1999) 0.86
Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administration. J Clin Pharmacol (1997) 0.86
Determination of in vivo adducts of disulfiram with mitochondrial aldehyde dehydrogenase. Biochem Pharmacol (2001) 0.86
Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide. Biochem Pharmacol (1997) 0.85
A noninvasive 'swish and spit' method for collecting nucleated cells for HLA typing by PCR in population studies. Hum Hered (1996) 0.84
A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration. Aliment Pharmacol Ther (1997) 0.84
Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis (1998) 0.84
Latamoxef-associated hypoprothrombinaemia. Lancet (1983) 0.83
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate. Inflamm Bowel Dis (1999) 0.82
Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol. J Pharmacol Exp Ther (1985) 0.81
Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite. Alcohol Clin Exp Res (1999) 0.81
Inhibition of recombinant human mitochondrial aldehyde dehydrogenase by two intermediate metabolites of disulfiram. Biochem Pharmacol (1998) 0.81
Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus. Vaccine (1997) 0.81
Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections. Am J Med (1983) 0.81
The influence of the HLA-DRB1*13 allele on measles vaccine response. J Investig Med (1996) 0.81
Cloning of a cDNA encoding a constitutively expressed rat liver cytosolic aldehyde dehydrogenase. Biochem Biophys Res Commun (1997) 0.80
Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes. Drug Metab Dispos (2001) 0.80
Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease. Clin Pharmacol Ther (1999) 0.80
Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood. J Chromatogr B Biomed Sci Appl (2001) 0.80
Inhibition of human mitochondrial aldehyde dehydrogenase by metabolites of disulfiram and structural characterization of the enzyme adduct by HPLC-tandem mass spectrometry. Adv Exp Med Biol (1999) 0.79
Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymes. Biochemistry (2000) 0.79
S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram. Alcohol Clin Exp Res (1996) 0.78
Identification of the protein-drug adduct formed between aldehyde dehydrogenase and S-methyl-N,N-diethylthiocarbamoyl sulfoxide by on-line proteolytic digestion high performance liquid chromatography electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom (2000) 0.78
A dose-ranging study of azathioprine pharmacokinetics after single-dose administration of a delayed-release oral formulation. J Clin Pharmacol (1997) 0.78
Inhibition of human mitochondrial aldehyde dehydrogenase by the disulfiram metabolite S-methyl-N,N-diethylthiocarbamoyl sulfoxide: structural characterization of the enzyme adduct by HPLC-tandem mass spectrometry. Biochem Pharmacol (1997) 0.77
Transcutaneous drug delivery: a practical review. Mayo Clin Proc (1995) 0.77
Cefotetan and hypoprothrombinemia. Ann Intern Med (1988) 0.77
Vitamin K-dependent carboxylase: mRNA distribution and effects of vitamin K-deficiency and warfarin treatment. Biochem Biophys Res Commun (1996) 0.77
Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase. J Pharmacol Exp Ther (1993) 0.76
Effect of a disulfiram metabolite on retinaldehyde metabolism. Lancet (1997) 0.76
Effect of enzyme inhibitors on protein quaternary structure determined by on-line size exclusion chromatography-microelectrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2001) 0.76
Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis. Arthritis Rheum (1999) 0.75
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease. Inflamm Bowel Dis (2000) 0.75
Cephalosporin-induced alteration in hepatic glutathione redox state. A potential mechanism for inhibition of hepatic reduction of vitamin K1,2,3-epoxide in the rat. J Clin Invest (1990) 0.75
Production of hypoprothrombinaemia by cefazolin and 2-methyl-1,3,4-thiadiazole-5-thiol in the rat. J Antimicrob Chemother (1986) 0.75
A preliminary report on the cloning of a constitutively expressed rat liver cytosolic ALDH cDNA by PCR. Adv Exp Med Biol (1997) 0.75
Suppression of graft-versus-host reactions by D- and L-chloramphenicol. Cell Immunol (1976) 0.75
Elevated cerebrospinal fuid norepinephrine in schizophrenics: confounding effects of treatment drugs. Science (1980) 0.75
Monosulfiram, disulfiram, and light. Lancet (1994) 0.75
S-methyl N,N-diethylthiocarbamate sulfone, a potential metabolite of disulfiram and potent inhibitor of low Km mitochondrial aldehyde dehydrogenase. Biochem Pharmacol (1995) 0.75
Cloning and expression of a cDNA encoding a constitutively expressed rat liver cytosolic aldehyde dehydrogenase. Adv Exp Med Biol (1999) 0.75
Simultaneous structure-activity determination of disulfiram photolysis products by on-line continuous-flow liquid secondary ion mass spectrometry and enzyme inhibition assay. J Chromatogr A (1995) 0.75
Photolysis of sulfiram: a mechanism for its disulfiram-like reaction. Biochem Pharmacol (1994) 0.75
Simultaneous determination of azathioprine and 6-mercaptopurine by high-performance liquid chromatography. J Chromatogr B Biomed Appl (1996) 0.75
Effect of biliary diversion on the ability of cefamandole to inhibit vitamin K metabolism. Drug Metabol Drug Interact (1989) 0.75
Microtiter plate-based determination of multiple concentration-inhibition relationships. Anal Biochem (1995) 0.75
S-methylation of diethyldithiocarbamic acid in rat liver microsomes. Xenobiotica (1996) 0.75
Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: technique and precision. Aliment Pharmacol Ther (1998) 0.75